Pelvic floor muscle training for bladder, bowel, and sexual function in spinal cord injury patients

Exploring the Feasibility and Urogenital Benefits of Pelvic Floor Muscle Training in Individuals With Motor-incomplete Spinal Cord Injury

Not applicable Interventional University of British Columbia · NCT06705790

This study is testing if a pelvic floor muscle training program can help people with spinal cord injuries improve their bladder, bowel, and sexual function.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment30 (estimated)
Ages19 Years and up
SexAll
SponsorUniversity of British Columbia Academic / other
Locations1 site (Vancouver, British Columbia)
Trial IDNCT06705790 on ClinicalTrials.gov

What this trial studies

This trial aims to evaluate the feasibility and potential benefits of a pelvic floor muscle training program for individuals with motor-incomplete spinal cord injury. Participants will engage in a 3-month training program, during which researchers will assess recruitment rates, adherence, and the program's impact on bladder, bowel, and sexual function. The study will involve a series of tests at the beginning, middle, and end of the program to gather data on its effectiveness and participant experiences.

Who should consider this trial

Good fit: Ideal candidates are adults aged 19 and older with non-progressive, motor-incomplete spinal cord injuries at or above the T12 level, experiencing related dysfunction.

Not a fit: Patients who are currently pregnant, have had recent urogenital surgery, or have severe medical issues may not benefit from this study.

Why it matters

Potential benefit: If successful, this program could significantly improve bladder, bowel, and sexual health for individuals with spinal cord injuries.

How similar studies have performed: While pelvic floor muscle training has been explored in other contexts, this specific application for spinal cord injury is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Are at least 19 years of age.
* Have a non-progressive, motor-incomplete spinal cord injury that is at or above the T12 neurological level at least 12 months ago.
* Have symptoms of bladder, bowel, and/or sexual dysfunction that are caused by your spinal cord injury.
* Have stable management of spinal cord related secondary health concerns (e.g., spasticity, neuropathic pain).
* Are able to speak and understand English.

Exclusion Criteria:

* Are currently pregnant, have been pregnant within the past 6 months, or are planning to become pregnant in the next 6 months.
* Have had urogenital surgery within the past 12 months.
* Have received Botox bladder injections within the past 4 weeks, or anticipate receiving an injection in the next 6 months.
* Have presence of severe medical issue that in the investigator's judgement would adversely affect the participant's participation in the study. Examples include, but are not limited to pressure sores, cardiovascular disease, and unmanaged diabetes.
* Have any permanent metal fixtures in their head (excluding dental fillings), or pacemakers, stimulators, or implanted medication pumps.
* Have a history of seizures, are taking medications that lower the seizure threshold, or experience recurring headaches.
* Have a condition for which exercise is contraindicated.

Where this trial is running

Vancouver, British Columbia

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Spinal Cord InjuryPelvic Floor Muscle TrainingBladderBowelSexual Health
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.